Nuvalent (NUVL) Interest & Investment Income (2022 - 2026)
Nuvalent's Interest & Investment Income was $12.9 million in Q1 2026, up 9.0% from $11.84 million a year earlier and up 11.2% from the prior quarter.
Nuvalent (NUVL) Interest & Investment Income (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nuvalent's Interest & Investment Income was $45.82 million through Mar 31, 2026, up 9.7% year-over-year; for FY2025, it was $44.8 million, up 16.7% from FY2024.
- Interest & Investment Income has now increased for three consecutive years, with a four-year compound annual growth rate of 345.2% (FY2021 to FY2025).
- In earlier years, Interest & Investment Income was $38.4 million in FY2024 (+64.8%), $23.3 million in FY2023 (+441.9%), $4.3 million in FY2022 and $114,000 in FY2021.
- The Q1 2026 figure marks the highest quarterly Interest & Investment Income since Q4 2024.
- Compared with a year earlier, Interest & Investment Income was higher in seven of the last eight quarters, with growth averaging 35.5%.
- The best year-over-year quarter for Interest & Investment Income over five years was Q3 2023 (growth of 664.6%); the worst was Q4 2025 (a decline of 11.5%).
- Per Business Quant data, NUVL's Interest & Investment Income in the three quarters before Q1 2026 was $11.6 million (Q4 2025), $10.2 million (Q3 2025) and $11.12 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 12.90 Mn |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 12.90 Mn |
| Dec 31, 2025 | 11.60 Mn |
| Sep 30, 2025 | 10.20 Mn |
| Jun 30, 2025 | 11.12 Mn |
| Mar 31, 2025 | 11.84 Mn |
| Dec 31, 2024 | 13.10 Mn |
| Sep 30, 2024 | 8.70 Mn |
| Jun 30, 2024 | 8.15 Mn |
| Mar 31, 2024 | 8.50 Mn |
| Dec 31, 2023 | 8.17 Mn |
| Sep 30, 2023 | 5.14 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Mar 31, 2023 | 5.02 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 672,000.00 |
| Jun 30, 2022 | 267,000.00 |
| Mar 31, 2022 | 139,000.00 |
Nuvalent Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NUVL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "NUVL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NUVL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();